FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940853908> ?p ?o ?g. }

• W2940853908 endingPage "747" @default.
• W2940853908 startingPage "734" @default.
• W2940853908 abstract "Abstract Background Early mobilization improves physical independency of critically ill patients at hospital discharge in a general intensive care unit (ICU)‐cohort. We aimed to investigate clinical and molecular benefits or detriments of early mobilization and muscle activating measures in a high‐risk ICU‐acquired weakness cohort. Methods Fifty patients with a SOFA score ≥9 within 72 h after ICU admission were randomized to muscle activating measures such as neuromuscular electrical stimulation or whole‐body vibration in addition to early protocol‐based physiotherapy (intervention) or early protocol‐based physiotherapy alone (control). Muscle strength and function were assessed by Medical Research Council (MRC) score, handgrip strength and Functional Independence Measure at first awakening, ICU discharge, and 12 month follow‐up. Patients underwent open surgical muscle biopsy on day 15. We investigated the impact of muscle activating measures in addition to early protocol‐based physiotherapy on muscle strength and function as well as on muscle wasting, morphology, and homeostasis in patients with sepsis and ICU‐acquired weakness. We compared the data with patients treated with common physiotherapeutic practice (CPP) earlier. Results ICU‐acquired weakness occurs within the entire cohort, and muscle activating measures did not improve muscle strength or function at first awakening (MRC median [IQR]: CPP 3.3 [3.0–4.3]; control 3.0 [2.7–3.4]; intervention 3.0 [2.1–3.8]; P > 0.05 for all), ICU discharge (MRC median [IQR]: CPP 3.8 [3.4–4.4]; control 3.9 [3.3–4.0]; intervention 3.6 [2.8–4.0]; P > 0.05 for all), and 12 month follow‐up (MRC median [IQR]: control 5.0 [4.3–5.0]; intervention 4.8 [4.3–5.0]; P = 0.342 for all). No signs of necrosis or inflammatory infiltration were present in the histological analysis. Myocyte cross‐sectional area in the intervention group was significantly larger in comparison with the control group (type I +10%; type IIa +13%; type IIb +3%; P < 0.001 for all) and CPP (type I +36%; type IIa +49%; type IIb +65%; P < 0.001 for all). This increase was accompanied by an up‐regulated gene expression for myosin heavy chains (fold change median [IQR]: MYH1 2.3 [1.1–2.7]; MYH2 0.7 [0.2–1.8]; MYH4 5.1 [2.2–15.3]) and an unaffected gene expression for TRIM63 , TRIM62 , and FBXO32 . Conclusions In our patients with sepsis syndrome at high risk for ICU‐acquired weakness muscle activating measures in addition to early protocol‐based physiotherapy did not improve muscle strength or function at first awakening, ICU discharge, or 12 month follow‐up. Yet it prevented muscle atrophy." @default.
• W2940853908 created "2019-05-03" @default.
• W2940853908 creator A5007799161 @default.
• W2940853908 creator A5013882441 @default.
• W2940853908 creator A5016186200 @default.
• W2940853908 creator A5018243297 @default.
• W2940853908 creator A5019636868 @default.
• W2940853908 creator A5030755453 @default.
• W2940853908 creator A5053647710 @default.
• W2940853908 creator A5054043894 @default.
• W2940853908 creator A5068813826 @default.
• W2940853908 creator A5071823133 @default.
• W2940853908 creator A5084942593 @default.
• W2940853908 creator A5085774780 @default.
• W2940853908 creator A5091778203 @default.
• W2940853908 date "2019-04-23" @default.
• W2940853908 modified "2023-10-15" @default.
• W2940853908 title "Muscle wasting and function after muscle activation and early protocol‐based physiotherapy: an explorative trial" @default.
• W2940853908 cites W1269086989 @default.
• W2940853908 cites W1978492957 @default.
• W2940853908 cites W1987647235 @default.
• W2940853908 cites W2011892153 @default.
• W2940853908 cites W2050048538 @default.
• W2940853908 cites W2060176865 @default.
• W2940853908 cites W2066161830 @default.
• W2940853908 cites W2068228146 @default.
• W2940853908 cites W2096061116 @default.
• W2940853908 cites W2109005423 @default.
• W2940853908 cites W2118240638 @default.
• W2940853908 cites W2124405724 @default.
• W2940853908 cites W2145878627 @default.
• W2940853908 cites W2152191498 @default.
• W2940853908 cites W2158881221 @default.
• W2940853908 cites W2193015193 @default.
• W2940853908 cites W2261776134 @default.
• W2940853908 cites W2326471898 @default.
• W2940853908 cites W2465839541 @default.
• W2940853908 cites W2488287465 @default.
• W2940853908 cites W2522882267 @default.
• W2940853908 cites W2525291310 @default.
• W2940853908 cites W2555448912 @default.
• W2940853908 cites W2562513273 @default.
• W2940853908 cites W2601336547 @default.
• W2940853908 cites W2765244546 @default.
• W2940853908 cites W2811363822 @default.
• W2940853908 cites W2885019064 @default.
• W2940853908 cites W2885896746 @default.
• W2940853908 doi "https://doi.org/10.1002/jcsm.12428" @default.
• W2940853908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6711421" @default.
• W2940853908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31016887" @default.
• W2940853908 hasPublicationYear "2019" @default.
• W2940853908 type Work @default.
• W2940853908 sameAs 2940853908 @default.
• W2940853908 citedByCount "48" @default.
• W2940853908 countsByYear W29408539082019 @default.
• W2940853908 countsByYear W29408539082020 @default.
• W2940853908 countsByYear W29408539082021 @default.
• W2940853908 countsByYear W29408539082022 @default.
• W2940853908 countsByYear W29408539082023 @default.
• W2940853908 crossrefType "journal-article" @default.
• W2940853908 hasAuthorship W2940853908A5007799161 @default.
• W2940853908 hasAuthorship W2940853908A5013882441 @default.
• W2940853908 hasAuthorship W2940853908A5016186200 @default.
• W2940853908 hasAuthorship W2940853908A5018243297 @default.
• W2940853908 hasAuthorship W2940853908A5019636868 @default.
• W2940853908 hasAuthorship W2940853908A5030755453 @default.
• W2940853908 hasAuthorship W2940853908A5053647710 @default.
• W2940853908 hasAuthorship W2940853908A5054043894 @default.
• W2940853908 hasAuthorship W2940853908A5068813826 @default.
• W2940853908 hasAuthorship W2940853908A5071823133 @default.
• W2940853908 hasAuthorship W2940853908A5084942593 @default.
• W2940853908 hasAuthorship W2940853908A5085774780 @default.
• W2940853908 hasAuthorship W2940853908A5091778203 @default.
• W2940853908 hasBestOaLocation W29408539081 @default.
• W2940853908 hasConcept C126322002 @default.
• W2940853908 hasConcept C141071460 @default.
• W2940853908 hasConcept C1862650 @default.
• W2940853908 hasConcept C2776376669 @default.
• W2940853908 hasConcept C2776418732 @default.
• W2940853908 hasConcept C2779764123 @default.
• W2940853908 hasConcept C2780247198 @default.
• W2940853908 hasConcept C71924100 @default.
• W2940853908 hasConcept C72563966 @default.
• W2940853908 hasConcept C99508421 @default.
• W2940853908 hasConceptScore W2940853908C126322002 @default.
• W2940853908 hasConceptScore W2940853908C141071460 @default.
• W2940853908 hasConceptScore W2940853908C1862650 @default.
• W2940853908 hasConceptScore W2940853908C2776376669 @default.
• W2940853908 hasConceptScore W2940853908C2776418732 @default.
• W2940853908 hasConceptScore W2940853908C2779764123 @default.
• W2940853908 hasConceptScore W2940853908C2780247198 @default.
• W2940853908 hasConceptScore W2940853908C71924100 @default.
• W2940853908 hasConceptScore W2940853908C72563966 @default.
• W2940853908 hasConceptScore W2940853908C99508421 @default.
• W2940853908 hasFunder F4320312069 @default.
• W2940853908 hasFunder F4320320879 @default.
• W2940853908 hasIssue "4" @default.
• W2940853908 hasLocation W29408539081 @default.

• next